Consumer Goods

CALGARY AB, June 10, 2026 /CNW/ - InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) ("InPlay" or the "Company") announced today the voting results for the election of directors at its annual meeting of shareholders held...

New collaboration brings Visa's global payment network to one of the largest AI platforms...

MONACO, June 10, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after the project submitted its CoinGecko listing as launch preparations continue to move forward. The presale has now crossed $1.49 million in total capital raised, Stage 17 is live at $0.01877, and holder growth has passed 9,400 while AlphaSwap demo traction and audit completion continue to support the project’s pre-listing profile.

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 7,142,857 shares of Humacyte’s common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being sold by Humacyte.

Toobit unveils Prediction Market, allowing traders to hedge risk and profit from crypto, financial, and global event forecasts using USDT.